NexoBrid Nexo Pharmaceuticals Pty Ltd
Product name
NexoBrid
Sponsor
Accepted date
Jul-2024
Active ingredients
anacaulase-bcdb
Proposed indication
For use as a temporary debriding agent/ removal of eschar in burns patients.
Application type
A (new medicine)
Publication date
Jul-2024
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.